Literature DB >> 30963306

An 18th century description of endometriosis : The autopsy of the Countess von Reitzenstein.

Robin M F van der Weiden1, Detlef Haberland2, Roland Sedivy3, Jan G van den Tweel4.   

Abstract

Descriptions of endometriosis in 18th century monographs and manuscripts are rare and the recorded macroscopic features of endometriosis seldom support this attribution to the described cases. Recently, we became aware of an anonymous German autopsy report from the 18th century. After transcription, the manuscript was assessed by pathologists with historical expertise. This revealed that the patient died because of a malignant tumor, most probably of a gynecological origin. Furthermore, the described ovarian pathologic findings strongly support the diagnosis endometriotic ovarian cyst. Like Giovanni Battista Morgagni (1668-1772) in his landmark publication De Sedibus et Causis Morborum per Anatomen Indagatis (1761), the author correlated the pathological findings at autopsy with the symptoms of the patient. The identity of the patient could, with high probability, be established as being the Countess of Reitzenstein, the wife of a Prussian general major in the army of Friedrich the Great: Karl Erdmann von Reitzenstein (1722-1789).

Entities:  

Keywords:  Abdominal neoplasm; Giovanni Battista Morgagni; Gynecology; History of endometriosis; Reitzenstein

Year:  2019        PMID: 30963306     DOI: 10.1007/s10354-019-0693-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  3 in total

1.  How old is endometriosis? Late 17th- and 18th-century European descriptions of the disease.

Authors:  V J Knapp
Journal:  Fertil Steril       Date:  1999-07       Impact factor: 7.329

2.  The history of endometriosis.

Authors:  Giuseppe Benagiano; Ivo Brosens; Donatella Lippi
Journal:  Gynecol Obstet Invest       Date:  2014-05-16       Impact factor: 2.031

3.  The rise and fall of the autopsy.

Authors:  Jan G van den Tweel; Clive R Taylor
Journal:  Virchows Arch       Date:  2013-03-07       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.